… Eisai will licence Shanghai Henlius Biotech’s lung cancer drug … are met, the Chinese drugmaker said on Thursday.  The … licensing agreement for the drug, approved in markets including … commercialisation of the drug as an injection. Eisai has been granted …

… serves as a bridge connecting pharmaceutical companies, universities, and research … the Government of Japan, multiple pharmaceutical companies, the Gates Foundation, Wellcome … Collaboration Partners 1. Eisai Co., Ltd. (Japan) 2. Drugs for Neglected Diseases …

… developing 110+ oncolytic virus drugs.  Key oncolytic virus companies … . Oncolytic Virus Market Analysis: Drug Profile IMLYGIC: Amgen IMLYGIC ( … Merck Sharp & Dohme, Eisai, Regeneron Pharmaceuticals, Iovance Biotherapeutics, Highlight Therapeutics, …

… Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib … which was originally developed by Eisai Co. Ltd. and was … toward FDA approval. About the Drug Response Predictor – DRP® … with a sufficiently high, drug-specific DRP score, the …

… for the development of drugs, diagnostics and vaccines for … of new drugs for Chagas disease being led by Eisai Co. … by Ehime University, Sumitomo Pharma Co., PATH, Statens Serum … -guided approaches for schistosomiasis drug discovery by Aberystwyth University …

… tyrosine kinase inhibitor discovered by Eisai. OncoMate ® MSI Detection Kit … , RNA and protein analysis; drug development; human identification and molecular … academic and government research, forensics, pharmaceuticals, clinical diagnostics and veterinary, …

… as Chugai, Daiichi Sankyo, Astellas, Eisai, Otsuka, and others, are focused … ., and Astellas Pharma Inc. signed an MoU to support drug-discovery startups … with investments from Takeda Pharmaceutical Company, Astellas Pharma Inc., and Sumitomo Mitsui …

… also became the fourth pharma partner for Repertoire Immune … mifepristone. The agency accepted Eisai and Biogen’s supplemental … Novartis’ Kisqali; Merck and Eisai’s Lenvima; Bristol Myers … Sanofi claimed its amlitelimab drug showed promising potential in …

Welcome to Fierce Pharma';s regulatory tracker … ET In Europe, Acadia Pharmaceuticals'; application for trofinetide in … has refiled its Hengrui Pharma-partnered combination of PD-1 … Biogen and Eisai’s application for Alzheimer’s disease drug Leqembi to …